Format

Send to

Choose Destination
Clin Chest Med. 2011 Sep;32(3):547-57. doi: 10.1016/j.ccm.2011.06.001.

Diagnosis of ventilator-associated respiratory infections (VARI): microbiologic clues for tracheobronchitis (VAT) and pneumonia (VAP).

Author information

1
Center for Infectious Disease & Prevention, Lahey Clinic Medical Center, Burlington, MA 01805, USA. donald.e.craven@lahey.org

Abstract

Intubated patients are at risk of bacterial colonization and ventilator-associated respiratory infection (VARI). VARI includes tracheobronchitis (VAT) or pneumonia (VAP). VAT and VAP caused by multidrug-resistant (MDR) pathogens are increasing in the United States and Europe. In patients with risk factors for MDR pathogens, empiric antibiotics are often initiated for 48 to 72 hours pending the availability of pathogen identification and antibiotic sensitivity data. Extensive data indicate that early, appropriate antibiotic therapy improves outcomes for patients with VAP. Recognizing and treating VARI may allow earlier appropriate therapy and improved patient outcomes.

PMID:
21867822
DOI:
10.1016/j.ccm.2011.06.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center